[LIN] Linde: Q3 2026 Earnings Preview, Home Care Margin Drag vs. Project Start-ups

Linde plc supplies oxygen, nitrogen, argon, hydrogen, helium and other industrial gases to steel mills, chemical plants, semiconductor fabs, hospitals and welders, and it designs and builds air separation and hydrogen plants for third parties[1]. Ahead of Linde's Q3 2026 earnings, the company has scheduled its call for 2026-10-30 to report the third quarter of 2026, ending September 30, 2026[2]. In the latest disclosed period, the second quarter of 2026, sales rose 9% to $9,289 million, adjusted operating profit reached $2,744 million at a 29.5% margin, down 60 basis points year over year, and adjusted EPS rose 10% to $4.50[3]. Linde guided third-quarter adjusted EPS to $4.45-$4.55, up 6%-8%, assuming no year-over-year currency effect[4]; the Drillr consensus from 13 analysts puts EPS at $4.52, and 10 analysts put revenue at $9.16 billion, slightly below the second-quarter actual and consistent with the roughly 1% sequential currency headwind management described[5][6].

Three things matter most in the coming report. First, can the Americas segment margin recover sequentially from 31.2% in the second quarter? Management attributed most of the consolidated margin decline to its U.S. home care business, Lincare, said Americas margins would have risen 20 basis points year over year without it, and named the third quarter as the first quarter of promised sequential improvement[7][8]. Second, can project start-ups keep adding about two points of volume growth? Half of second-quarter volume growth came from new projects in APAC and the Americas, and the company plans more than 20 start-ups in the rest of 2026, which begins converting the $8.1 billion backlog into gas supply revenue[9]. Third, can operating cash flow keep pace with full-year capex guidance raised to $5.5-$6.0 billion? First-half operating cash flow grew only 3%, working capital absorbed $989 million, and second-quarter free cash flow of $833 million was below the first quarter's $898 million[4][10][11].

Company Background and Business Structure

Linde is an industrial gases company formed in 2018 by the merger of Germany's Linde AG and U.S.-based Praxair; it is incorporated in Ireland, headquartered in Woking, UK, listed on Nasdaq and led by CEO Sanjiv Lamba[3]. Its business has two parts: the gases business produces atmospheric gases such as oxygen, nitrogen and argon and process gases such as hydrogen, helium and carbon dioxide, while the engineering business designs and builds air separation, hydrogen, natural gas processing and olefin plants for third parties[1]. In 2025, the three geographic segments, the Americas, EMEA (Europe, Middle East and Africa) and APAC, generated 90% of sales, with the rest mainly from Engineering[1].

By geography, the Americas is Linde's largest segment. Of $33,986 million in 2025 sales, the Americas contributed $15,208 million (about 45%, with $4,747 million of operating profit at a 31.2% margin), EMEA $8,549 million (about 25%, $3,055 million at 35.7%), APAC $6,661 million (about 20%, $1,933 million at 29.0%), Engineering $2,250 million ($408 million of operating profit) and Other $1,318 million[12]. By distribution method, packaged gas brought in $11,853 million (35%), merchant liquid $10,159 million (30%) and on-site supply $8,083 million (24%), while the remaining $3,891 million (11%) was mostly engineering revenue[13]. By end market, management said on the first-quarter call that healthcare is about 16% of global sales and chemicals and energy about 22%, with healthcare including the U.S. home care business Lincare[14].

Linde's three distribution methods carry different contract lengths and customer sizes, which determines how stable revenue is. For the largest, steadiest users such as steel mills, chemical plants and semiconductor fabs, Linde builds plants on or next to the customer's site and supplies by pipeline under total requirement contracts that typically run 10-20 years with minimum purchase requirements and price escalation clauses; mid-sized customers receive liquid by tanker into storage tanks Linde leases to them under contracts of about 3-7 years; and small users buy cylinders under 1-3 year contracts or purchase orders[15]. A single air separation plant often serves both pipeline and liquid channels, while liquid oxygen and nitrogen can only be shipped economically within a fairly small radius of the plant[15]. Energy is the largest single cost in producing and distributing industrial gases, and Linde passes energy price swings to customers through pricing formulas, surcharges and cost pass-through clauses, while it buys most hydrogen, helium and carbon dioxide feedstock from outside suppliers[16].

Financial History and Current Position

Since 2022, Linde's annual sales have stayed near $33 billion, and profit growth has come mainly from pricing and productivity savings. Sales for 2021 through 2025 were $30,793 million, $33,364 million, $32,854 million, $33,005 million and $33,986 million, while net income rose from $3,826 million to $6,898 million over the same period[17]. In 2025, sales grew 3%, with 2 points from price and 1 point from acquisitions, while volumes were flat because base volume declines were largely offset by new project start-ups; adjusted operating profit rose 4% to $10,137 million at a 29.8% margin, diluted EPS was $14.61 and adjusted EPS rose 6% to $16.46[17][12]. That year, operating cash flow was $10,350 million, capex $5,261 million, dividends $2,811 million, net share repurchases $4,578 million and net borrowing $2,911 million[17].

In the first half of 2026, Linde kept growing sales and EPS, but its margin started to slip. First-quarter sales rose 8% to $8,781 million, including 5 points from currency, adjusted operating profit was $2,630 million at a 30.0% margin, and adjusted EPS rose 10% to $4.33[11]. Second-quarter sales rose 9% to $9,289 million, made up of price +2%, volume +2%, currency +2%, acquisitions +1%, cost pass-through +1% and engineering +1%[18]; adjusted operating profit rose 7% to $2,744 million, the margin fell 60 basis points to 29.5%, GAAP net income was $1,928 million, and adjusted EPS rose 10% to $4.50 with diluted shares down 2% year over year[3][18].

First-half operating cash flow clearly lagged profit growth. Operating cash flow for the six months was $4,511 million, up 3%, against capex of $2,780 million, net share repurchases of $1,656 million and dividends of $1,479 million; net borrowing rose by $1,645 million, and cash stood at $4,898 million at the end of June[10][19]. By quarter, free cash flow was $898 million in the first quarter and $833 million in the second[11][3].

Operating Model

Linde's sales break down into volume, price, energy cost pass-through, engineering revenue and currency, and each part affects profit differently. Packaged and merchant gases run mainly on 1-7 year contracts and purchase orders, so volumes move with customer operating rates and prices reset every year, making them the main source of price increases; on-site supply runs on 10-20 year total requirement contracts, grows mainly through new project start-ups, and passes energy price changes to customers under contract, which changes revenue but barely changes profit[15][18]. After a new project starts up, it still needs 2-3 years of execution and ramp-up before reaching full margin contribution, so today's backlog corresponds to on-site revenue several years out[9]. Businesses outside the U.S. operate in local currencies, so translation moves reported revenue noticeably: currency added 5 points in the first quarter of 2026 and 2 points in the second[11][3].

Segment operating profit equals sales minus variable costs, fixed costs and depreciation, and the margin depends mainly on whether pricing and productivity savings outrun inflation in labor, logistics and other costs. In 2025, segment variable costs were $13,313 million, fixed costs and other $7,550 million, and depreciation and amortization $2,986 million[20]. In the second quarter of 2026, the consolidated margin fell to 29.5%, or about 30 basis points lower year over year excluding cost pass-through; management attributed the decline to labor and reimbursement pressure at U.S. home care, double-digit growth in lower-margin U.S. hard goods such as welding equipment, and lower-margin equipment sales to electronics customers in APAC[8]. GAAP operating profit also deducts purchase accounting amortization from the Linde AG merger, $941 million in 2025, plus $273 million of cost reduction program and other charges[12].

Operating cash flow equals net income plus depreciation minus changes in working capital, and the on-site model means capex runs about 2-3 years ahead of gas supply revenue. In 2025, operating cash flow of $10,350 million less capex of $5,261 million left free cash flow of about $5,089 million, dividends and net buybacks together exceeded that amount, and net borrowing filled the gap; about 60% of that year's capex was in the Americas and 21% in APAC[17][21]. A larger backlog means higher capex now: the company raised 2026 capex guidance from $5.0-$5.5 billion in May to $5.5-$6.0 billion, and management said the increase comes from newly won projects, including the large U.S. electronics win, and higher base capex for commercial space activity[4][6]. In the first half of 2026, receivables absorbed $651 million and contract assets $288 million, which is the main reason operating cash flow grew more slowly than net income[10].

Industry and Competitive Position

Industrial gases is an oligopoly in which competition happens region by region, and the density of its pipeline networks is Linde's main advantage. Linde's annual report lists competitors including L'Air Liquide, Air Products, Messer and Taiyo Nippon Sanso, part of Mitsubishi Chemical, along with many local producers and distributors, and customer-owned plants account for a significant share of the international gases market[22]. Because liquid oxygen and nitrogen travel only short distances, Linde says that where it has pipeline networks it can supply large customers reliably and economically, which gives it a competitive advantage[22]. On profitability, the CEO described the second quarter's 29.5% operating margin and 23.5% return on capital as industry-leading[3]; the available disclosures do not include competitors' figures for the same period, so this comparison rests on the company's own description.

Linde's growth is tilting toward electronics, while commercial space faces a headwind from customers building their own supply. Management called electronics the fastest-growing end market, driven by new project start-ups and AI-related hardware demand, said the second quarter added about $1 billion of U.S. advanced semiconductor fab backlog, noted that an $800 million Taiwanese joint venture is not included in the backlog, and expects electronics to remain the largest backlog contributor over the long term[9]. In the first quarter, the electronics end market grew 10%, mainly from investment in advanced chips for AI[14]. On the other side, some large commercial space customers are building their own plants for atmospheric propellant gases, which could affect future gas volumes, although management does not expect this to affect hydrogen for space applications[6].

Core Debates

With an $8.1 billion on-site project backlog entering its start-up phase, can project start-ups keep adding about two points of volume growth in the third quarter?

Project start-ups are Linde's main source of growth while base volumes are weak, so their timing directly determines whether volumes keep contributing. For full-year 2025, volumes were flat, with base volume declines largely offset by new start-ups[17]; in the second quarter of 2026, volumes added 2 points to consolidated sales, management said about half came from project start-ups in APAC and the Americas, and on-site revenue rose 9.4% to $2,190 million[9][23]. The backlog, which measures the capital cost of large plants under construction rather than contracted revenue, rose from $7.3 billion at the end of 2025 and $7.1 billion at the end of March 2026 to a record $8.1 billion at the end of June; the company plans more than 20 start-ups representing about $1.3 billion of capital in the rest of 2026 and still expects to exit the year with a backlog above $8 billion[21][24][19][9].

Start-ups reach the financial statements in two steps, and the first step can depress margins before the second lifts revenue. Once customers draw gas under minimum-purchase contracts, on-site revenue and consolidated volume grow; but lower-margin equipment sales recognized in the meantime dilute APAC margins in the short run, and in the second quarter APAC volumes added 6 points from new start-ups and equipment sales while the segment margin fell 120 basis points to 28.4%[25][7]. There is also contrary evidence: part of the Woodside project slipped to the first quarter of 2027 because of construction delays, and new projects need 2-3 years of ramp-up to reach full margin contribution[14][9]. An alternative explanation is that part of second-quarter volume growth came from one-off equipment deliveries rather than continuing gas supply, so the third-quarter volume contribution could fall back to about 1 point.

The third-quarter report can test whether start-ups are converting into continuing gas supply as planned. The items to watch are whether consolidated volume adds at least 2 points and how much of that comes from start-ups, whether on-site revenue growth exceeds the combined effect of currency and cost pass-through, whether the APAC margin returns to around 29%, whether the backlog at the end of September is at least $8 billion, and whether the call announces new project delays. If the volume contribution falls to zero or below and the company blames project delays, or if the backlog drops below $7.3 billion without new wins, the view that the backlog is entering start-up and replacing base volume would weaken.

With U.S. home care dragging on Americas margins, can remediation lift the Americas margin sequentially in the third quarter and keep EPS inside the $4.45-$4.55 guidance?

The Americas contributes about 45% of Linde's sales and 47% of segment profit, so its margin path directly determines whether the consolidated margin and EPS hold to guidance[12]. Second-quarter Americas sales rose 7% to $4,083 million and operating profit was $1,272 million at a 31.2% margin, down 50 basis points, whereas the first-quarter Americas margin was 31.6%, up 60 basis points[7][26]. Management said the Americas margin decline came almost entirely from the U.S. home care business Lincare and that Americas margins would have risen 20 basis points without it; the business faces both labor cost inflation and unfavorable reimbursement policy changes, and the company has installed new management, pruned the portfolio and is evaluating full or partial strategic alternatives, including a sale[8].

Evidence for and against a sequential recovery sits side by side. In favor, first-half Americas operating profit rose 8%, the company raised the low end of full-year adjusted EPS guidance by 10 cents to $17.70, and weaker second-half margins in 2025 make the year-over-year comparison easier[27][4][6]. Against it, Americas pricing slowed from 4 points in the first quarter to 2 points in the second, and growth in U.S. hard goods is also diluting margins[26][27][8]. An alternative explanation is that Lincare's problem is structural, so sequential improvement would depend on a sale rather than operating fixes, and slower pricing would make it hard for the Americas margin to keep rising even excluding Lincare.

The financial chain in this debate ends at EPS. Rising home care labor costs and lower reimbursement cut Lincare's profit and pull down the Americas segment margin; changes in pricing and productivity savings then flow through the adjusted operating margin to EPS. Management said the midpoint of third-quarter guidance implies a 5 cent sequential EPS increase from the second quarter excluding currency, driven by ongoing margin improvement actions, and that it will give more detail on additional cost actions on the third-quarter call[6]. The report should show whether the Americas margin returns above 31.2% toward 31.6%, whether Americas pricing stays at 2 points or more, whether adjusted EPS is at least $4.50, and whether the company announces a decision to sell or keep Lincare; an Americas margin below 31.2% or adjusted EPS below $4.45 would falsify the sequential recovery view.

After several quarters of falling European volumes, can EMEA volumes stabilize in the third quarter so that its margin above 35% no longer rests only on pricing and cost cuts?

EMEA is Linde's highest-margin region, but its recent profit growth has come almost entirely from sources other than volume. In 2025, EMEA operating profit grew 10% at a 35.7% margin, while volumes reduced sales by 3 points, so the profit growth came from pricing, cost cuts and currency[12][28]. In 2026, the EMEA volume contribution narrowed from -3 points in the first quarter to -1 point in the second, and the second-quarter margin was 35.7%, down 40 basis points year over year but up 10 basis points excluding cost pass-through[26][29][7].

Volume determines how much room the EMEA margin has left, because the segment carries high fixed costs. EMEA fixed costs and other were $1,870 million in 2025, and operating rates at European manufacturing, chemical and energy customers drive merchant and packaged gas volumes, so a volume recovery would spread those fixed costs while further declines would magnify their weight[20]. Evidence for stabilization is that group packaged gas revenue grew 6.5% in the second quarter[23]; evidence against it is that the second-quarter EMEA decline was concentrated in manufacturing, on-site chemicals and energy customers had already shifted capacity in the first quarter, company guidance assumes no macro improvement in the second half, and Middle East tensions have raised helium dislocation costs[29][14][6]. An alternative explanation is that the narrower second-quarter decline reflects an easy base rather than recovering demand, leaving third-quarter volumes still around -2 points.

The third-quarter report can show whether EMEA's high margin is starting to get volume support. The items to watch are whether the EMEA volume contribution returns to zero or better, whether the margin holds at 35.7% or more, whether group packaged gas revenue grows at least 5%, and whether management pushes back its timing for a helium recovery; management said earlier that the helium market will not normalize until early 2027 even if Strait of Hormuz tensions ease this year[6]. If EMEA volumes fall to -2 points or worse, or the margin drops below 35.0%, the room to sustain a high margin through pricing and cost cuts alone is shrinking.

After capex guidance was raised to $5.5-$6.0 billion, can third-quarter operating cash flow keep pace so that free cash flow stops declining?

Linde funds plants up front and recovers the investment through multi-year supply contracts, so higher capex secures more future growth but leaves less free cash flow today. In 2025, dividends of $2,811 million and net buybacks of $4,578 million together came to about $7.4 billion, more than that year's free cash flow[17]; in the first half of 2026, net borrowing rose by $1,645 million and operating cash flow grew only 3%, while net income including noncontrolling interests rose from $3,513 million to $3,872 million, about 10%[10].

Both the supporting and the contrary evidence point to working capital. In support, operating cash flow is still growing, and the capex increase is tied to the contracted $8.1 billion backlog rather than speculative expansion[19][4]. Against it, first-half receivables absorbed $651 million and contract assets $288 million, far above $309 million and $22 million a year earlier, first-half capex rose $253 million or about 10%, and second-quarter free cash flow of $833 million was below the first quarter's $898 million[10][19][3][11]. An alternative explanation is that the working capital build reflects timing differences from equipment sales and revenue growth that will partly reverse in the third quarter, making the free cash flow decline temporary.

The financial chain in this debate decides how far shareholder returns depend on borrowing. New project wins and base investment for commercial space raise capex, project billing terms and equipment sales raise receivables and contract assets, and together they compress free cash flow, which in turn decides how much of the dividend and buyback relies on net borrowing. The report should show whether operating cash flow for the first nine months grows at least 3%, whether third-quarter capex is consistent with the $5.5-$6.0 billion full-year guidance, whether the working capital build narrows from the first half, and whether third-quarter free cash flow is at least $833 million. If nine-month operating cash flow declines year over year, or capex guidance is raised again, concern that cash conversion cannot keep pace with investment would grow.

Risks and Falsifiers

Currency translation is the most direct variable in whether third-quarter EPS lands inside the guidance range. More than half of Linde's sales come from outside the U.S., currency added 5 points to sales in the first quarter and 2 points in the second, and third-quarter guidance assumes no year-over-year currency effect but about a 1% headwind versus the second quarter[11][18][6]. On second-quarter sales of $9,289 million, a 1-point currency swing is worth about $90 million of quarterly sales; if the third-quarter report shows a currency effect consistent with the no-impact assumption, this risk did not materialize.

Delays in project start-ups would push back both volume growth and capital returns. Part of the Woodside project has already slipped to the first quarter of 2027, and new projects need 2-3 years of ramp-up to reach full margin contribution[14][9]. Against second-quarter on-site revenue of about $2,190 million, each point of volume contribution corresponds to roughly $90 million of quarterly sales[23][18]; if the third-quarter report confirms start-ups on schedule and a volume contribution of at least 2 points, this risk is falsified.

Reimbursement and labor pressure at home care could keep squeezing Americas profit, and a fix or a sale could itself bring charges. On second-quarter Americas sales of $4,083 million, each 0.5-point drop in the Americas margin removes about $20 million of quarterly operating profit, and a sale could produce a one-time loss and lower revenue[7][8]. If the third-quarter Americas margin returns above 31.6% and the company presents a clear plan, this risk is falsified.

Helium supply disruption from Middle East tensions makes it hard for higher helium prices to reach profit. Tensions around the Strait of Hormuz and the wider Persian Gulf have disrupted helium supply chains, forcing Linde to source product at higher cost to meet its contracts, while industrial activity in hydrocarbon-dependent Asian markets such as India, parts of ASEAN and Australia has been held back[6]. In the first quarter, Linde said its helium business was 85%-90% contracted and that helium sales were flat as prices fell and volumes rose[14]; the company does not disclose helium revenue or costs, so the effect can only be inferred from segment pricing and margins. If the third-quarter report shows helium prices rising while dislocation costs fall, with APAC and EMEA pricing holding at 2 points, this risk would recede.

Rising capex and working capital at the same time would squeeze free cash flow and make shareholder returns more dependent on borrowing. The company raised full-year capex guidance by $500 million; in the first half, working capital absorbed $989 million and free cash flow was $1,731 million, while dividends and net buybacks totaled $3,135 million, with borrowing covering the gap[4][10]. If nine-month operating cash flow grows at least 3% and the working capital build narrows, this risk is falsified.

What to Watch Next

• Project start-ups and base volume: consolidated volume added 2 points in the second quarter and the backlog was $8.1 billion at the end of June. At least 2 points of volume and a backlog of $8 billion or more would confirm the view; zero or negative volume blamed on delays, or a backlog below $7.3 billion, would falsify it. On-site revenue growth (9.4% in the second quarter) above currency plus pass-through, and an APAC margin back near 29% from 28.4%, would add support.
• Americas margin and Lincare: the Americas margin was 31.2% with 2 points of pricing in the second quarter. A margin above 31.2% moving toward 31.6%, plus a decision on selling or keeping Lincare, would confirm recovery; a margin below 31.2% would falsify it.
• EPS against guidance: adjusted EPS was $4.50 in the second quarter against third-quarter guidance of $4.45-$4.55. EPS of at least $4.50 would support the recovery view; EPS below $4.45 would falsify it.
• European volume: EMEA volume was -1 point, the EMEA margin 35.7% and packaged gas growth 6.5% in the second quarter. Volume at zero or better with a margin of at least 35.7% would confirm stabilization; volume at -2 points or worse, a margin below 35.0% or a later helium recovery date would falsify it.
• Cash conversion after higher capex: second-quarter operating cash flow was $2,271 million, capex $1,438 million and free cash flow $833 million, with a $989 million first-half working capital build. Nine-month operating cash flow growth of at least 3% with a narrower working capital build would confirm; a year-over-year decline in operating cash flow or another capex guidance increase would falsify.

Conclusion

Linde's business runs on long-term supply contracts, annual price increases and new project start-ups, and the open question now is whether margins and cash conversion can keep up with revenue growth. Second-quarter sales grew 9% and adjusted EPS 10%, but the consolidated margin fell to 29.5%, the Americas margin to 31.2%, first-half operating cash flow grew only 3%, and the $8.1 billion backlog and $5.5-$6.0 billion full-year capex mean the next few years remain an investment phase[3][7][10][19][4]. The central unresolved relationship is whether Lincare's drag is a temporary problem that can be fixed within a few quarters or a structural one that needs a sale, and whether start-up volumes can turn into lasting profit and cash once equipment sales and the working capital build fade.

Outside views published after the second-quarter results split clearly on margins. Simply Wall St wrote on August 2 that about half of the roughly 60 basis point margin decline could not be explained by cost pass-through, that Lincare still faces reimbursement and labor pressure under strategic review, and that converting the $8.1 billion backlog into sustainable profit carries execution risk while margins weaken[30]. Investing.com reported on September 4 that UBS, after meeting Linde's CFO, considers the Lincare and helium challenges to be under management and unlikely to weigh on 2027 earnings, with the company cutting costs and restructuring Lincare and expecting improvement in the third quarter, and with improving volumes and backlog contributions supporting double-digit EPS growth into 2027[31]. Both accept that Lincare is the main current drag on margins; they differ on whether it is a temporary problem fixable within a few quarters or a persistent pressure that undermines the conversion of backlog into profit, and both remain outside interpretations rather than established facts.

If the third-quarter report shows the Americas margin back near 31.6%, consolidated volume adding at least 2 points, EMEA volumes stabilizing, a narrower working capital build and nine-month operating cash flow growth of at least 3%, the view that margin pressure is temporary and the backlog is replacing base volume would strengthen markedly. Conversely, if the Americas margin stays below 31.2%, adjusted EPS falls below $4.45, project start-ups slip again, or capex guidance rises again while free cash flow keeps falling, the cautious reading of execution risk would gain more support.

Sources

[1] LIN 10-K filed 2026-02-25 · business overview and end markets · 2026-02-25 · 10-K · https://www.sec.gov/Archives/edgar/data/1707925/000162828026011430/

[2] Drillr earnings calendar (updated 2026-09-29) · LIN 2026-10-30 call · 2026-09-29 · Drillr earnings calendar · https://gateway.drillr.ai/mcp/private

[3] LIN 8-K filed 2026-07-31 · Q2 2026 results · 2026-07-31 · 8-K · https://www.sec.gov/Archives/edgar/data/0001707925/000165495426007052/lin_ex991.htm

[4] LIN 8-K filed 2026-07-31 · Q3 and full-year 2026 guidance · 2026-07-31 · 8-K · https://www.sec.gov/Archives/edgar/data/0001707925/000165495426007052/lin_ex991.htm

[5] Drillr analyst_financial_estimates (updated 2026-09-29) · LIN quarter ending 2026-09-30 · 2026-09-29 · Drillr analyst_financial_estimates · https://gateway.drillr.ai/mcp/private

[6] LIN Q2 2026 earnings call 2026-07-31 · guidance, helium and capital deployment · 2026-07-31 · earnings-call · https://gateway.drillr.ai/mcp/private

[7] LIN 8-K filed 2026-07-31 · Q2 2026 segment results · 2026-07-31 · 8-K · https://www.sec.gov/Archives/edgar/data/0001707925/000165495426007052/lin_ex991.htm

[8] LIN Q2 2026 earnings call 2026-07-31 · segment performance and home care · 2026-07-31 · earnings-call · https://gateway.drillr.ai/mcp/private

[9] LIN Q2 2026 earnings call 2026-07-31 · backlog, start-ups and end markets · 2026-07-31 · earnings-call · https://gateway.drillr.ai/mcp/private

[10] LIN 10-Q filed 2026-07-31 · cash flow six months 2026 · 2026-07-31 · 10-Q · https://www.sec.gov/Archives/edgar/data/1707925/000162828026051289/

[11] LIN 8-K filed 2026-05-01 · Q1 2026 results · 2026-05-01 · 8-K · https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001707925&type=8-K&dateb=&owner=include&count=40

[12] LIN 10-K filed 2026-02-25 · segment sales and operating profit FY2024-FY2025 · 2026-02-25 · 10-K · https://www.sec.gov/Archives/edgar/data/1707925/000162828026011430/

[13] LIN 10-K filed 2026-02-25 · sales by distribution method FY2023-FY2025 · 2026-02-25 · 10-K · https://www.sec.gov/Archives/edgar/data/1707925/000162828026011430/

[14] LIN Q1 2026 earnings call 2026-05-01 · end markets, helium and project timing · 2026-05-01 · earnings-call · https://gateway.drillr.ai/mcp/private

[15] LIN 10-K filed 2026-02-25 · industrial gases distribution methods · 2026-02-25 · 10-K · https://www.sec.gov/Archives/edgar/data/1707925/000162828026011430/

[16] LIN 10-K filed 2026-02-25 · energy and raw material costs · 2026-02-25 · 10-K · https://www.sec.gov/Archives/edgar/data/1707925/000162828026011430/

[17] LIN 10-K filed 2026-02-25 · 2025 year in review · 2026-02-25 · 10-K · https://www.sec.gov/Archives/edgar/data/1707925/000162828026011430/

[18] LIN 10-Q filed 2026-07-31 · Q2 2026 consolidated results · 2026-07-31 · 10-Q · https://www.sec.gov/Archives/edgar/data/1707925/000162828026051289/

[19] LIN 10-Q filed 2026-07-31 · capex and sale of gas backlog June 2026 · 2026-07-31 · 10-Q · https://www.sec.gov/Archives/edgar/data/1707925/000162828026051289/

[20] LIN 10-K filed 2026-02-25 · segment cost structure FY2025 · 2026-02-25 · 10-K · https://www.sec.gov/Archives/edgar/data/1707925/000162828026011430/

[21] LIN 10-K filed 2026-02-25 · 2025 capital expenditures and sale of gas backlog · 2026-02-25 · 10-K · https://www.sec.gov/Archives/edgar/data/1707925/000162828026011430/

[22] LIN 10-K filed 2026-02-25 · competition · 2026-02-25 · 10-K · https://www.sec.gov/Archives/edgar/data/1707925/000162828026011430/

[23] LIN 10-Q filed 2026-07-31 · sales by distribution method Q2 2026 · 2026-07-31 · 10-Q · https://www.sec.gov/Archives/edgar/data/1707925/000162828026051289/

[24] LIN 10-Q filed 2026-05-01 · Q1 2026 capex and sale of gas backlog · 2026-05-01 · 10-Q · https://www.sec.gov/Archives/edgar/data/1707925/000162828026029165/

[25] LIN 10-Q filed 2026-07-31 · APAC sales and operating profit Q2 2026 · 2026-07-31 · 10-Q · https://www.sec.gov/Archives/edgar/data/1707925/000162828026051289/

[26] LIN 8-K filed 2026-05-01 · Q1 2026 segment results · 2026-05-01 · 8-K · https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001707925&type=8-K&dateb=&owner=include&count=40

[27] LIN 10-Q filed 2026-07-31 · Americas sales and operating profit Q2 2026 · 2026-07-31 · 10-Q · https://www.sec.gov/Archives/edgar/data/1707925/000162828026051289/

[28] LIN 10-K filed 2026-02-25 · EMEA sales 2025 · 2026-02-25 · 10-K · https://www.sec.gov/Archives/edgar/data/1707925/000162828026011430/

[29] LIN 10-Q filed 2026-07-31 · EMEA sales and operating profit Q2 2026 · 2026-07-31 · 10-Q · https://www.sec.gov/Archives/edgar/data/1707925/000162828026051289/

[30] Simply Wall St 2026-08-02 · Linde (LIN) Stock Reprices As Margin Slippage Clouds Record Sales · 2026-08-02 · Simply Wall St · https://simplywall.st/stocks/us/materials/nasdaq-lin/linde/news/linde-lin-stock-reprices-as-margin-slippage-clouds-record-sa

[31] Investing.com 2026-09-04 · UBS view on Linde cost cuts after CFO meeting · 2026-09-04 · Investing.com(UBS 观点) · https://www.investing.com/news/analyst-ratings/linde-stock-price-target-reaffirmed-at-612-by-ubs-on-cost-cuts-93CH-4889728